| Normal group n = 11,494 | Good control group n = 300 | Intermediate control group n = 105 | Poor control group n = 80 |
---|---|---|---|---|
Age, years, mean (SD) | 49.0 (5.7) | 53.3 (5.2) | 53.2 (4.9) | 51.3 (5.1) |
Gender, % | ||||
 Male | 76.9 | 95.7 | 92.4 | 93.7 |
 Female | 23.1 | 4.3 | 7.6 | 6.3 |
Employment status, % | ||||
 Full-time | 97.8 | 96.9 | 98.0 | 98.7 |
 Contract | 2.0 | 2.8 | 2.0 | 1.3 |
 Part-time or Temporary | 0.1 | 0.3 | 0 | 0 |
Occupation, % | ||||
 Managerial | 39.7 | 42.1 | 41.3 | 26.9 |
 Clerical | 15.9 | 10.2 | 10.9 | 11.9 |
 Sales | 20.5 | 34.6 | 26.1 | 46.3 |
 Research & Development | 10.5 | 4.3 | 7.6 | 3.0 |
 Engineering | 4.6 | 3.1 | 3.3 | 1.5 |
 Production line | 8.1 | 4.7 | 8.7 | 10.4 |
 Other | 0.8 | 0.8 | 2.2 | 0 |
Smoking status, % | 20.1 | 31.7 | 31.4 | 28.8 |
BMI (kg/m2), mean (SD) | 23.0 (3.1) | 26.5 (4.3) | 26.8 (3.8) | 28.1 (3.9) |
Fasting blood glucose (mg/dL), mean (SD) | 91.6 (7.6) | 118.9 (20.3) | 142.1 (25.2) | 184.0 (46.9) |
HbA1c (NGSP) (%), mean (SD) | 5.4 (0.3) | 6.3 (0.4) | 7.4 (0.3) | 9.2 (1.4) |
Therapy type, % | ||||
 Monotherapy | – | 48.7 | 29.5 | 16.3 |
 Combination therapy | – | 51.3 | 70.5 | 83.8 |
Quantity of work, mean (SD) | 9.0 (1.7) | 8.9 (1.7) | 8.7 (2.1) | 8.7 (2.2) |
Quality of work, mean (SD) | 8.9 (1.8) | 8.9 (1.8) | 8.6 (2.1) | 8.4 (2.4) |
Presenteeism loss, mean (SD) | 16.8 (24.4) | 17.6 (24.8) | 21.8 (27.7) | 22.7 (30.7) |
Symptom days in the past month, mean (SD) | 8.3 (10.4) | 9.1 (10.9) | 9.3 (11.0) | 9.0 (10.2) |